Inflammatory Bowel Diseases

Cover image for Vol. 15 Issue 11

November 2009

Volume 15, Issue 11

Pages 1609–1768

  1. Letters to the Editor

    1. Top of page
    2. Letters to the Editor
    3. Editorials
    4. Original Clinical Articles
    5. Original Basic Science Articles
    6. Clinical Reviews
    7. Selected Summaries
    1. Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)? (pages 1609–1610)

      Stephanie Ingram, Joseph M. McKinley, Frank Vasey, John D. Carter and Patrick G. Brady

      Version of Record online: 18 DEC 2008 | DOI: 10.1002/ibd.20841

    2. Successful use of adalimumab in treating cutaneous metastatic Crohn's disease: Report of a case (pages 1611–1612)

      Faith A. Miller, Christopher R. Jones, Loren E. Clarke, Zenwu Lin, David R. Adams and Walter A. Koltun

      Version of Record online: 17 DEC 2008 | DOI: 10.1002/ibd.20853

    3. Cholestatic hepatitis, acute acalculous cholecystitis, and hemolytic anemia: primary Epstein–Barr virus infection under azathioprine (pages 1613–1616)

      Stefan Hagel, Tony Bruns, Marcus Kantowski, Peter Fix, Thomas Seidel and Andreas Stallmach

      Version of Record online: 9 JAN 2009 | DOI: 10.1002/ibd.20856

    4. Upregulation of T-bet and tight junction molecules by Bifidobactrium longum improves colonic inflammation of ulcerative colitis (pages 1617–1618)

      Yasuhiro Takeda, Hiroshi Nakase, Kazuyoshi Namba, Satoko Inoue, Satoru Ueno, Norimitsu Uza and Tsutomu Chiba

      Version of Record online: 22 JAN 2009 | DOI: 10.1002/ibd.20861

  2. Editorials

    1. Top of page
    2. Letters to the Editor
    3. Editorials
    4. Original Clinical Articles
    5. Original Basic Science Articles
    6. Clinical Reviews
    7. Selected Summaries
    1. Cervical neoplasia risk in IBD: Truth or hysteria? (pages 1619–1620)

      Uma Mahadevan

      Version of Record online: 30 APR 2009 | DOI: 10.1002/ibd.20957

  3. Original Clinical Articles

    1. Top of page
    2. Letters to the Editor
    3. Editorials
    4. Original Clinical Articles
    5. Original Basic Science Articles
    6. Clinical Reviews
    7. Selected Summaries
    1. Lack of association between cervical dysplasia and IBD: A large case–control study (pages 1621–1629)

      C.W. Lees, J. Critchley, N. Chee, T. Beez, R.E. Gailer, A.R. Williams, A.G. Shand, I.D.R. Arnott and J. Satsangi

      Version of Record online: 17 JUL 2009 | DOI: 10.1002/ibd.20959

    2. Severity of postoperative recurrence in crohn's disease: Correlation between endoscopic and sonographic findings (pages 1635–1642)

      Emma Calabrese, Carmelina Petruzziello, Sara Onali, Giovanna Condino, Francesca Zorzi, Francesco Pallone and Livia Biancone

      Version of Record online: 30 APR 2009 | DOI: 10.1002/ibd.20948

    3. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease (pages 1643–1655)

      Carl D. Kirkwood, Josef Wagner, Karen Boniface, Jill Vaughan, Wojtek P. Michalski, Anthony G. Catto-Smith, Don J.S. Cameron and Ruth F. Bishop

      Version of Record online: 21 MAY 2009 | DOI: 10.1002/ibd.20967

    4. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients (pages 1656–1662)

      Pál Miheller, Györgyi Műzes, István Hritz, Gábor Lakatos, István Pregun, Péter László Lakatos, László Herszényi and Zsolt Tulassay

      Version of Record online: 30 APR 2009 | DOI: 10.1002/ibd.20947

    5. Magnifying colonoscopy used to predict disease relapse in patients with quiescent ulcerative colitis (pages 1663–1669)

      Chiyuki Watanabe, Masaaki Sumioka, Tomoki Hiramoto, Ikue Noda, Sayaka Oba, Morihisa Akagi, Mikiya Kitamoto, Hiroyasu Yamada and Masaru Imagawa

      Version of Record online: 5 JUN 2009 | DOI: 10.1002/ibd.20949

    6. Pediatric Crohn's disease activity at diagnosis, its influence on pediatrician's prescribing behavior, and clinical outcome 5 years later (pages 1670–1677)

      Tamara Mesker, Patrick F. van Rheenen, Obbe F. Norbruis, Jan Uitentuis, Herman J. Waalkens, Gieneke Gonera, Lidy A.T. van Overbeek, Joke Butler and Edmond H.H.M. Rings

      Version of Record online: 5 MAY 2009 | DOI: 10.1002/ibd.20950

  4. Original Basic Science Articles

    1. Top of page
    2. Letters to the Editor
    3. Editorials
    4. Original Clinical Articles
    5. Original Basic Science Articles
    6. Clinical Reviews
    7. Selected Summaries
    1. Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis (pages 1678–1685)

      Martin A. Storr, Catherine M. Keenan, Hong Zhang, Kamala D. Patel, Alexandros Makriyannis and Keith A. Sharkey

      Version of Record online: 30 APR 2009 | DOI: 10.1002/ibd.20960

    2. MDP-Induced selective tolerance to TLR4 ligands: Impairment in NOD2 mutant Crohn's disease patients (pages 1686–1696)

      Elisabet Cantó, Esther Moga, Elena Ricart, Orlando Garcia-Bosch, Esther Garcia-Planella, Candido Juarez and Silvia Vidal

      Version of Record online: 1 JUL 2009 | DOI: 10.1002/ibd.21013

    3. Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: A Study in the Spanish population and a meta-analysis (pages 1697–1704)

      Ana Márquez, Concepción Núñez, Alfonso Martínez, Juan Luis Mendoza, Carlos Taxonera, Miguel Fernández-Arquero, Manuel Díaz-Rubio, Emilio G. de la Concha and Elena Urcelay

      Version of Record online: 2 JUL 2009 | DOI: 10.1002/ibd.21001

    4. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesis (pages 1705–1720)

      Annika Braun, Irina Treede, Daniel Gotthardt, Anke Tietje, Alexandra Zahn, Rebecca Ruhwald, Ulrike Schoenfeld, Thilo Welsch, Peter Kienle, Gerhard Erben, Wolf-Dieter Lehmann, Joachim Fuellekrug, Wolfgang Stremmel and Robert Ehehalt

      Version of Record online: 5 JUN 2009 | DOI: 10.1002/ibd.20993

    5. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease (pages 1721–1736)

      C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hörmannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller and D. Kelly

      Version of Record online: 28 JUL 2009 | DOI: 10.1002/ibd.20999

    6. Phylogenetic analysis of inflammatory bowel disease associated Escherichia coli and the fimH virulence determinant (pages 1737–1745)

      Shadi Sepehri, Roman Kotlowski, Charles N. Bernstein and Denis O. Krause

      Version of Record online: 21 MAY 2009 | DOI: 10.1002/ibd.20966

  5. Clinical Reviews

    1. Top of page
    2. Letters to the Editor
    3. Editorials
    4. Original Clinical Articles
    5. Original Basic Science Articles
    6. Clinical Reviews
    7. Selected Summaries
    1. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease (pages 1746–1754)

      Javier P. Gisbert, Adrian G. McNicholl and Fernando Gomollon

      Version of Record online: 10 APR 2009 | DOI: 10.1002/ibd.20920

    2. Strategies to improve quality of life in adolescents with inflammatory bowel disease (pages 1755–1764)

      Christine A. Karwowski, David Keljo and Eva Szigethy

      Version of Record online: 26 MAY 2009 | DOI: 10.1002/ibd.20919

  6. Selected Summaries

    1. Top of page
    2. Letters to the Editor
    3. Editorials
    4. Original Clinical Articles
    5. Original Basic Science Articles
    6. Clinical Reviews
    7. Selected Summaries
    1. Stress in the ER leads to inflammatory bowel disease (pages 1765–1766)

      Matthew J. Hamilton and Richard L. Stevens

      Version of Record online: 30 APR 2009 | DOI: 10.1002/ibd.20969

SEARCH

SEARCH BY CITATION